Clinical Trial Update: Effects of Pulsatile Intravenous Insulin Delivery on Hypoglycemic Unawareness [Phase 2, Phase 3]

View source ↗

Summary

Florida Atlantic University-led trial evaluating pulsatile intravenous insulin delivery for hypoglycemic unawareness has been withdrawn from Phase 2 and Phase 3…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycemia

Drugs mentioned

• Insulin (insulin)

Snippet

Sponsor: Florida Atlantic University | Conditions: Hypoglycemia | Phase 2, Phase 3 | Status: WITHDRAWN